期刊文献+

B淋巴细胞刺激因子及其受体与系统性红斑狼疮的相关性研究

Correlation of B Lymphocyte Stimulator and Its Receptor with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的探讨B淋巴细胞刺激因子(BLyS)及其特异性受体(BAFF-R)与系统性红斑狼疮(SLE)的相关性。方法 SLE患者33例,根据SLE疾病活动指数(SLEDAI)评分,分为活动组20例和缓解组13例。同期体检健康者30例为对照组。应用酶联免疫吸附试验法检测3组研究对象血清BLyS、BAFF-R水平,观察SLE患者血清BLyS、BAFF-R水平与抗核抗体(ANA)、抗双链DNA抗体(ds-DNA)、白细胞(WBC)、补体C3、C4和SLEDAI评分的相关性。结果活动组患者血清BLyS、BAFF-R水平均明显高于缓解组及对照组(P<0.05),缓解组患者血清BLyS水平明显高于对照组(P<0.05),但缓解组与对照组血清BAFF-R水平比较,差异无统计学意义(P>0.05);SLE患者血清BLyS、BAFF-R水平均与SLEDAI呈正相关关系(P<0.05);BLyS水平与ANA呈正相关关系(P<0.05);BAFF-R与ANA无明显相关关系(P>0.05);SLE患者血清BLyS、BAFF-R水平与ds-DNA无明显相关关系(P>0.05);SLE患者血清BLyS、BAFF-R水平与WBC、C3、C4水平均呈负相关关系(P<0.05)。结论 SLE患者血清BLyS、BAFF-R水平与SLE病情密切相关,对SLE病情的评价有重要价值,且BLyS可能比BAFF-R更有效。 Objective To investigate the correlation of B lymphocyte stimulator ( BLyS ) and its receptor B cell-activating factor receptor ( BAFF-R ) with systemic lupus erythematosus ( SLE ) .Methods Thirty-three SLE patients were divided into active group(n=20) and remission group(n=13) according to the SLE disease activity index(SLEDAI), 30 healthy volunteers as control group .The serum levels of BLyS and BAFF-R were measured by enzyme-linked immuno sorbent assay(ELISA) among patients in the three groups.The correlation of serum levels of BLyS and BAFF-R,ANA, ds-DNA,WBC,C3,C4 with SLEDAI score was analyzed .Results The serum levels of BLyS and BAFF-R of patients in the active group were significantly higher than those in the remission group and control group ( P〈0.05) ,the serum BLyS level in the remission group was significantly higher than that in the control group (P〈0.05).But there was no significant difference in the surum BAFF-R level between remission group and control group ( P 〉0 .05 ) .SLEDAI positively correlated with the serum levels of BLyS and BAFF-R among SLE patients(P〈0.05),and ANA positively correlate with BLyS level(P〈0.05).No significant correlation existed between BAFF-R and ANA.The serum levels of BLyS and BAFF-R didn′t correlate with ds-DNA( P〉0.05) ,but negatively correlated with WBC ,C3 and C4 levels among&amp;nbsp;SLE patients(P〈0.05).Conclusion The serum levels of BLyS and its receptor BAFF-R closely correlate with SLE, which can be used as an index of evaluating SLE condition and prognosis ,and BLyS might be much better than BAFF-R.
出处 《广西医学》 CAS 2014年第3期281-284,共4页 Guangxi Medical Journal
基金 广西自然科学基金资助项目(2010GXNSFA013186) 广西医药卫生科研课题(Z2010378)
关键词 系统性红斑狼疮 B淋巴细胞刺激因子 B淋巴细胞刺激因子受体 系统性红斑狼疮疾病活动指数 抗核抗体 Systemic lupus erythematosus B lymphocyte stimulator factor B cell-activating factor receptor SLE disease activity index Antinuclear antibody
  • 相关文献

参考文献12

  • 1Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis actor family and B lymphocyte stimulator [ J ]. Science, 1999,285 (5 425 ) :260 - 263.
  • 2Ng LG, Sutherland AP, Newtar R, et al. B cell-activating fac- tor belonging to the TNF family( BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells[J]. J Immunol,2004,173(2):807 -817.
  • 3Shu HB,Hu W,Johnson H,et al. TALL-1 is a novel mem- ber of the TNF family that is down-regulated by mitogens [ J ]. J Leukoc Biol, 1999,65 (5-) :680 - 683.
  • 4Schneider P, MacKay F, Steineer V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth[J]. J Exp Med,1999,189( 11 ) :1 747 - 1 756.
  • 5Hochberg MC. Updating the American College of Rheuma- tology revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1997,40 ( 9 ) : 1 725.
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients [ J ]. Arthritis Rheum, 1992,35 (6) : 630 - 640.
  • 7Gross JA,Johnston J,Mudri S,et al. TACI and BCMA are re- ceptors for a TNF homologue implicated in B-cell autoim- mune disease [ J ]. Nature,2000,404 (6 781 ) :995 - 999.
  • 8Tribouley C, Wallroth M, Chan V, et al. Characterization of a new member of the TNF family expressed on antigen presen- ting cells[J]. Biol Chem,1999,380(12) :1 443 - 1 447.
  • 9Wang H, Marsters SA, Baker T, et al. TACI-ligand interac- tions are required for T cell activation and collagen-induced arthritis in mic [ J ]. Nat Immunol,2001,2 (7) : 632 - 637.
  • 10李东升,李家文.B淋巴细胞刺激物与系统性红斑狼疮的研究进展[J].国外医学(皮肤性病学分册),2003,29(5):291-293. 被引量:3

二级参考文献28

  • 1Gross JA,Johnston J,Mudri S,et al.TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.Nature,2000,404:995-999.
  • 2Thompson JS,Bixler SA,Qian F,et al.BAFF-R,a newly identified TNF receptor that specifically interacts with BAFF.Science,2001,293:2108-2111.
  • 3Ng LG,Sutherland AP,Newton R,et al.B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.J Immunol,2004,173:807-817.
  • 4Mackay F,Woodcock SA,Lawton P,et al.Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.J Exp Med,1999,190:1697-1710.
  • 5Khare SD,Sarosi I,Xia XZ,et al.Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.Proc Natl Acad Sci U S A,2000,97:3370-3375.
  • 6Yu G,Boone T,Delaney J,et al.APRIL and TALL-I and receptors BCMA and TACI:system for regulating humoral immunity.Nat Immunol,2000,1:252-256.
  • 7Stohl W.Systemic lupus erythematosus:a blissless disease of too much BLyS (B lymphocyte stimulator) protein.Curr Opin Rheumatol,2002,14:522-528.
  • 8Gescuk BD, Davis JC Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol, 2002, 14(5) :515 -521.
  • 9Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis racer family and B lymphocyte stimulator. Science, 1999,285 (5425) :260 - 263.
  • 10Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necroais factor family, stimulates B cell growth. J Exp Med,1999, 189(11 ) :1747 - 1756.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部